drugset

drugset / Trial / NCT02205255

BACE Trial Substudy 2 - FarmEc Substudy

NCT02205255 ↗

Phase 3 Completed 350 enrolled Wim Janssens

RandomizedParallel-groupTriple-blindTreatment

Summary

A second sub-analysis of the BACE trial will include a detailed cost-effectiveness study.

Timeline

Start: 2014-08-01
Primary completion: 2018-04
Completion: 2020-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azithromycin	Small molecule	250 mg	Oral

Indications